This is the authors' abstract. We don't add key points for this paper.
Background Alexithymia is a typical clinical manifestation of prolonged methamphetamine use and risk transdiagnostic factor for emotion-based psychiatric disorders. Kratom (Mitragyna speciosa) co-consumption is becoming prevalent among methamphetamine users in Southeast Asia. Given its therapeutic value in mitigating mood disorders, it was hypothesized that methamphetamine users self-manage alexithymia effects with kratom.Methods A total of 367 male methamphetamine users with and without kratom use history participated in this cross-sectional study. Validated scales encompassing the Malay version of the Kratom Dependence Scale (KDS), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Toronto Alexithymia Scale (TAS-20), and Visual Analogue Scale (VAS) were administered.Results The level of alexithymia in methamphetamine users with kratom use history did not differ significantly from methamphetamine users without kratom use history. Similarly, among methamphetamine users with kratom use history, their alexithymia level did not contrast significantly across groups based on their duration (short vs. long-term) of methamphetamine and kratom use history. Indeed, only current age, age of first illicit drug use history, and anxiety were predictors for alexithymia level in methamphetamine users with kratom use history.Conclusions Kratom consumption cannot significantly predict alexithymia level. Its regular use did not appear to alleviate alexithymia in methamphetamine users.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: